Filing Flows › Accendra Health (ACH) › Q3 2026
Accendra Health (ACH) Q3 2026 earnings results (third quarter 2026)
10-Q filed Nov 6, 2026
Accendra Health (ACH) reported revenue of $602M for the third quarter 2026 (Q3 2026), -14% from a year earlier and -2% from the quarter before. Operating margin was 0.2%, net loss $19.7M (3.3% of revenue).
Accendra Health, Q3 2026: revenue $602M (-14% year over year), operating margin 0.2%, net loss $19.7M, operating cash flow −$17.4M. The chart follows the revenue to costs, profit and cash.
| Q3 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $602M | -2% | -14% |
| Operating profit | $1.3M | — | -95% |
| Net earnings | −$19.7M | — | — |
| Operating cash flow | −$17.4M | — | — |
What changed
Revenue was $601.8M in Q3 2026, down 14% year over year and down 2% from the previous quarter. Diabetes was the largest line at 33% of revenue. Sleep therapy lost $41.3M year over year (down 22%), 43% of the total change.
Operating profit was $1.3M, a 0.2% margin (down 3.6 points year over year). Total costs fell 10% while revenue fell 14%. The quarter ended with a net loss of $19.7M, narrower than the previous quarter's $89.1M loss. Net interest and other expense of $39.9M was the main reason.
Operating cash flow was −$17.4M. Non-cash charges added back $38.9M of depreciation and amortization and $2.1M of share-based compensation. Working capital and other items used $38.7M. Capital expenditures of $39.2M exceeded it, leaving free cash flow of −$56.6M.
Questions
What was Accendra Health's revenue in the third quarter 2026?
Accendra Health (ACH) reported revenue of $602M for the third quarter 2026 (Q3 2026), -14% from a year earlier and -2% from the quarter before.
Was Accendra Health profitable in the third quarter 2026?
Operating profit was $1.3M (0.2% of revenue) and net loss $19.7M.
Source: Accendra Health 10-Q on SEC EDGAR.